Alvotech
- Last sale
- Nov 12, 2026 · -5.18%
- Market cap
- $1.46B
- 312.02M shares
- Filings
- 304
FY 2025+19.7% FY25 yoy
FY 2025N/M FY25 yoy
FY 2025+12.3% FY25 yoy
FY 2025derivedN/M FY25 yoy
FY 2025N/M FY25 yoy
FY 2025+235.1% FY25 yoy
- $1.46B
- 52.2×
- 2.5×
- —
- -7.87%
- 0.00%
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $586,321,000 | reported | |
| FY 2024 | 2024-12-31 | $489,682,000 | reported | |
| FY 2023 | 2023-12-31 | $91,434,000 | reported | |
| FY 2022 | 2022-12-31 | $83,029,000 | reported | |
| FY 2021 | 2021-12-31 | $36,772,000 | reported | |
| FY 2020 | 2020-12-31 | $66,616,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | $0.00 | — | $0.00 | — | 312.02M sh | +3.4% | — |
| FY2024 | $0.00 | — | $0.00 | — | 301.81M sh | +13.1% | — |
| FY2023 | $0.00 | — | $0.00 | — | 266.82M sh | +7.3% | — |
| FY2022 | $0.00 | — | $0.00 | — | 248.65M sh | — | — |
| FY2021 | $0.00 | — | $0.00 | — | — | — | — |
Biological products, except diagnostic substances
Alvotech is the 13th largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
NVAXNovavax Inc$1.1B64.7%39.2%$1.4BBCRXBiocryst Pharmaceuticals Inc$874.8M94.1%30.2%$2.0BRGENRepligen Corp$738.3M16.4%6.6%$10.7B
ALVOAlvotech (this company)$586.3M19.7%4.8%$1.5B
ADMAAdma Biologics, Inc.$510.2M19.6%28.8%$2.9BTWSTTwist Bioscience Corp$459.4M22.0%28.3%$7.8BTARSTarsus Pharmaceuticals, Inc.$451.4M146.7%14.7%$3.8BIMCRImmunocore Holdings plc$400.0M29.0%8.9%$1.6BKRYSKrystal Biotech, Inc.$389.1M33.9%52.6%$9.1BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Alvotech · CIK 1898416 · Engraved from SEC EDGAR